sorafenib has been researched along with trazodone in 3 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (trazodone) | Trials (trazodone) | Recent Studies (post-2010) (trazodone) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 1,466 | 295 | 312 |
| Protein | Taxonomy | sorafenib (IC50) | trazodone (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.091 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.909 | |
| D(2) dopamine receptor | Homo sapiens (human) | 4.485 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.017 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.281 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.389 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 1.942 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.311 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.281 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.265 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.1315 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.091 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.311 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.192 | |
| Histamine H1 receptor | Homo sapiens (human) | 0.361 | |
| D(3) dopamine receptor | Homo sapiens (human) | 3.743 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.107 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.281 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 2.203 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for sorafenib and trazodone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for sorafenib and trazodone
| Article | Year |
|---|---|
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |